Evidence map›Paper›PMID 34888430›Full record

ArticleContemporary clinical trials communications2021

Addressing intersectional stigma as a care barrier for HIV-positive people who inject drugs: Design of an RCT in St. Petersburg, Russia.

Sarah L Rossi, Yuliia Sereda, Jason B Luoma, Nikolai Pavlov, Olga Toussova, Janna Vasileva, Kristina Abramova, Sally Bendiks, Tetiana Kiriazova, Marina Vetrova and 5 more

Open access · goldAbstract read
In one paragraph

Article in Contemporary clinical trials communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Sarah L RossiDepartment of Medicine, Section of General Internal Medicine, Boston Medical Center, Clinical Addiction Research and Education (CARE) Unit, 801 Massachusetts Avenue, 2nd Floor, Boston, MA, 02118, United States.
Yuliia SeredaUkrainian Institute on Public Health Policy, Kyiv, Ukraine.
Jason B LuomaPortland Psychotherapy Clinic, Research, and Training Center, 3700 North Williams Avenue, Portland, OR, 97227, United States.
Nikolai PavlovLife in Balance Psychotherapy Clinic, 137 Roncesvalles Avenue, Suite 208, Toronto, ON M6R 2L2, Canada.
Olga ToussovaPavlov University, L'va Tolstogo St. 6-8, St. Petersburg, 197022, Russian Federation.
Janna VasilevaPavlov University, L'va Tolstogo St. 6-8, St. Petersburg, 197022, Russian Federation.
Kristina AbramovaPavlov University, L'va Tolstogo St. 6-8, St. Petersburg, 197022, Russian Federation.
Sally BendiksDepartment of Medicine, Section of General Internal Medicine, Boston Medical Center, Clinical Addiction Research and Education (CARE) Unit, 801 Massachusetts Avenue, 2nd Floor, Boston, MA, 02118, United States.
Tetiana KiriazovaUkrainian Institute on Public Health Policy, Kyiv, Ukraine.
Marina VetrovaPavlov University, L'va Tolstogo St. 6-8, St. Petersburg, 197022, Russian Federation.
Elena BlokhinaPavlov University, L'va Tolstogo St. 6-8, St. Petersburg, 197022, Russian Federation.
Evgeny KrupitskyPavlov University, L'va Tolstogo St. 6-8, St. Petersburg, 197022, Russian Federation.
Dmitry LioznovPavlov University, L'va Tolstogo St. 6-8, St. Petersburg, 197022, Russian Federation.
Sara LodiDepartment of Biostatistics, Boston University School of Public Health, 801 Massachusetts Avenue, 3rd Floor, Boston, MA, 02118, United States.
Karsten LunzeDepartment of Medicine, Section of General Internal Medicine, Boston Medical Center, Clinical Addiction Research and Education (CARE) Unit, 801 Massachusetts Avenue, 2nd Floor, Boston, MA, 02118, United States.
First Pavlov State Medical University of St. Petersburg · RUBoston Medical Center · USUkrainian Institute of Public Health Policy · UABoston University · USWilliams (United States) · US

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI LARRY K BROWN · 1998 to 2026
$51.7M
Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject DrugsR00DA041245 · NIDA · BOSTON MEDICAL CENTER · PI LUNZE, KARSTEN · 2018 to 2020
$906k
Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject DrugsK99DA041245 · NIDA · BOSTON MEDICAL CENTER · PI LUNZE, KARSTEN · 2016 to 2017
$355k
NIAID NIH HHS P30 AI042853NIDA NIH HHS K99 DA041245NIDA NIH HHS R00 DA041245
6 · The paper itself

Abstract

backgroundHIV-positive people who inject drugs (PWID) experience stigma related to their substance use and HIV, with adverse consequences to their health care utilization and mental health. To help affected individuals cope with their intersectional stigma and reduce its negative impact on health and health care, we adapted a behavioral stigma coping intervention for this HIV key population.

objectiveTo conduct a randomized controlled trial (RCT) testing the 'Stigma Coping to Reduce HIV risks and Improve substance use Prevention and Treatment' (SCRIPT) intervention, a community-based, adapted form of Acceptance and Commitment Therapy (ACT), for PWID living with HIV in St. Petersburg, Russia.

methodsWe recruited 100 PWID living with HIV from civil society organizations (CSO) delivering harm reduction and HIV prevention services in St. Petersburg, Russia. We randomized participants 2:1 to receive either the intervention (three adapted ACT sessions in a group format over one month and usual CSO care) or usual CSO care alone. ACT aims to help affected individuals cope with stigma by increasing their psychological flexibility to handle stigma-related negative expectations, emotions and experiences. The primary outcomes were satisfaction with the intervention, and changes in HIV and substance use stigma scores.

conclusionsStigma coping interventions targeting HIV-positive PWID outside of formal health care settings may help them confront negativities in their lives originating from intersectional stigma and reduce stigma's impact as a health care barrier.

Indexed as

BehavioralHIVPLWHPWIDRussiaStigma

Identifiers

PMID34888430
PMCPMC8636824
OpenAlexW3215325239

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.